SPY313.78-3.27 -1.03%
DIA259.04-3.96 -1.51%
IXIC10,343.89-89.76 -0.86%

HC Wainwright & Co. Initiates Coverage On BELLUS Health with Buy Rating, Announces Price Target of $28

HC Wainwright & Co. analyst Andrew Fein initiates coverage on BELLUS Health (NASDAQ:BLU) with a Buy rating and announces Price Target of $28.

Benzinga · -
HC Wainwright & Co. analyst Andrew Fein initiates coverage on BELLUS Health (NASDAQ: BLU) with a Buy rating and announces Price Target of $28.